Managing Ptosis in Your Practice

In this ODwire.org webinar, Melissa Barnett, OD and Susan Resnick, OD help us learn more about ptosis, including causes, diagnosis, treatment landscape, impact on patients, and opportunity for your practice.

Jason Bacharach, MD, introduces the first and only FDA-approved pharmacologic treatment for acquired blepharoptosis, RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, including its mechanism of action and clinical data.

Registered users may discuss in our forum!

  • ODwire.org is the largest site online specifically designed for Eye Care Professionals.

    If you're interested in practice management or obtaining clinical advice from your peers, you've come to the right place.

    We feature private forums, discussions, classifieds, webinars, podcasts and more.

    The site has over 19,000 clinician members, and have been running the site since 1999!

    Join us today!
  • Get In Touch

    Don’t forget to follow us on our social media to keep updated about the latest optometry news.